320 related articles for article (PubMed ID: 16584109)
21. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
Maślanka K; Michur H; Zupańska B; Uhrynowska M; Nowak J
Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
[TBL] [Abstract][Full Text] [Related]
22. Transfusion-related acute lung injury (TRALI): a case report and literature review.
Donelan KJ; Anderson KA
S D Med; 2011 Mar; 64(3):85-8. PubMed ID: 21473518
[TBL] [Abstract][Full Text] [Related]
23. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
[TBL] [Abstract][Full Text] [Related]
24. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.
Nakagawa M; Toy P
Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981
[TBL] [Abstract][Full Text] [Related]
25. Transfusion-related acute lung injury resulting from designated blood transfusion between mother and child: a report of two cases.
Yang X; Ahmed S; Chandrasekaran V
Am J Clin Pathol; 2004 Apr; 121(4):590-2. PubMed ID: 15080312
[TBL] [Abstract][Full Text] [Related]
26. Alloexposed blood donors and transfusion-related acute lung injury: a case-referent study.
Middelburg RA; van Stein D; Atsma F; Wiersum-Osselton JC; Porcelijn L; Beckers EA; Briët E; van der Bom JG
Transfusion; 2011 Oct; 51(10):2111-7. PubMed ID: 21985044
[TBL] [Abstract][Full Text] [Related]
27. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
[TBL] [Abstract][Full Text] [Related]
28. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
29. TRALI risk reduction: donor and component management strategies.
Eder AF; Benjamin RJ
J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
[TBL] [Abstract][Full Text] [Related]
30. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
31. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
Kleinman S; Grossman B; Kopko P
Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
[TBL] [Abstract][Full Text] [Related]
32. Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI.
Middelburg RA; Beckers EA; Porcelijn L; Lardy N; Wiersum-Osselton JC; Schipperus MR; Vrielink H; Briët E; van der Bom JG
Transfus Med; 2012 Apr; 22(2):128-32. PubMed ID: 22380759
[TBL] [Abstract][Full Text] [Related]
33. Are we underestimating reverse TRALI?
De Clippel D; Emonds MP; Compernolle V
Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
[TBL] [Abstract][Full Text] [Related]
34. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
[TBL] [Abstract][Full Text] [Related]
35. Transfusion-related acute lung injury (TRALI) in graft by blood donor antibodies against host leukocytes.
Goodwin J; Tinckam K; denHollander N; Haroon A; Keshavjee S; Cserti-Gazdewich CM
J Heart Lung Transplant; 2010 Sep; 29(9):1067-70. PubMed ID: 20627626
[TBL] [Abstract][Full Text] [Related]
36. Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.
Porretti L; Coluccio E; Prati D; Colombo MB; Lopa R; Tombolini P; Ambrosone A; Crespiatico L; Scalamogna M; Rebulla P
Eur J Haematol; 2004 Oct; 73(4):295-9. PubMed ID: 15347317
[TBL] [Abstract][Full Text] [Related]
37. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
Bux J
Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
[TBL] [Abstract][Full Text] [Related]
38. Transfusion-related acute lung injury during plasma exchange: Suspecting the unsuspected.
Askari S; Nollet K; Debol SM; Brunstein CG; Eastlund T
J Clin Apher; 2002; 17(2):93-6. PubMed ID: 12210713
[TBL] [Abstract][Full Text] [Related]
39. Implementation of a strategy to prevent TRALI in a regional blood centre.
Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
[TBL] [Abstract][Full Text] [Related]
40. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
Sachs UJ; Kauschat D; Bein G
Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
